Depakote - 0074-6212-13 - (Divalproex Sodium)

Alphabetical Index


Drug Information of Depakote

Product NDC: 0074-6212
Proprietary Name: Depakote
Non Proprietary Name: Divalproex Sodium
Active Ingredient(s): 125    mg/1 & nbsp;   Divalproex Sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Depakote

Product NDC: 0074-6212
Labeler Name: AbbVie Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018723
Marketing Category: NDA
Start Marketing Date: 19830310

Package Information of Depakote

Package NDC: 0074-6212-13
Package Description: 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-6212-13)

NDC Information of Depakote

NDC Code 0074-6212-13
Proprietary Name Depakote
Package Description 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-6212-13)
Product NDC 0074-6212
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Divalproex Sodium
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 19830310
Marketing Category Name NDA
Labeler Name AbbVie Inc.
Substance Name DIVALPROEX SODIUM
Strength Number 125
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]

Complete Information of Depakote


General Information